Arlin Murray L
Int J Oral Maxillofac Implants. 2006 Sep-Oct;21(5):769-76.
The purpose was to evaluate clinical outcome of short (6- and 8-mm) dental implants placed in sites with low bone availability (7 to 11 mm) in a single private practice and to compare their survival with that of longer implants.
Implants were placed by a single private practitioner in a variety of clinical indications. Exclusion criteria included uncontrolled diabetes mellitus, alcoholism, and systemic immune disorders. Clinical data relating to implant placement and follow-up appointments, including adverse events, were entered into an electronic database. Two-year survival rates were calculated and life table analyses undertaken for implants measuring 6, 8, and 10 to 16 mm.
A total of 630 Straumann implants were placed in 264 patients between April 1994 and December 2003. Of these, 35 implants were 6 mm long, 141 were 8 mm long, and 454 were 10 to 16 mm long. Maximum follow-up was 64.6 months, 83.7 months, and 102 months for implants measuring 6 mm, 8 mm, and 10 to 16 mm, respectively. Two-year survival rates were 94.3%, 99.3%, and 97.4% for 6-mm, 8-mm, and 10- to 16-mm implants, respectively.
The results indicated that the 2-year outcome for 6-mm and 8-mm implants was comparable to that for longer (10- to 16-mm) implants in this patient population.
In this study, short (6- or 8-mm) implants were used with good reliability in patients with limited bone availability, without the need for ridge augmentation. Shorter implant length was not associated with reduced survival at 2 years, compared with longer implants.
本研究旨在评估在一家私人诊所中,植入骨量较少(7至11毫米)部位的短种植体(6毫米和8毫米)的临床效果,并将其存活率与长种植体进行比较。
由一名私人执业医生在多种临床适应症下植入种植体。排除标准包括未控制的糖尿病、酗酒和全身性免疫疾病。将与种植体植入及随访预约相关的临床数据,包括不良事件,录入电子数据库。计算了6毫米、8毫米以及10至16毫米种植体的两年存活率,并进行了生命表分析。
1994年4月至2003年12月期间,共为264名患者植入了630枚士卓曼种植体。其中,35枚种植体长6毫米,141枚长8毫米,454枚长10至16毫米。6毫米、8毫米以及10至16毫米种植体的最长随访时间分别为64.6个月、83.7个月和102个月。6毫米、8毫米以及10至16毫米种植体的两年存活率分别为94.3%、99.3%和97.4%。
结果表明,在该患者群体中,6毫米和8毫米种植体的两年临床效果与较长(10至16毫米)种植体相当。
在本研究中,短种植体(6毫米或8毫米)在骨量有限的患者中使用具有良好的可靠性,无需进行牙槽嵴增量。与长种植体相比,较短的种植体长度在两年时并未导致存活率降低。